Log in

NASDAQ:ATOS - Atossa Genetics Stock Price, Forecast & News

$1.43
+0.04 (+2.88 %)
(As of 12/13/2019 04:00 PM ET)
Today's Range
$1.38
Now: $1.43
$1.43
50-Day Range
$1.21
MA: $1.48
$1.75
52-Week Range
$0.80
Now: $1.43
$7.39
Volume41,199 shs
Average Volume82,847 shs
Market Capitalization$13.06 million
P/E RatioN/A
Dividend YieldN/A
Beta3.21
Atossa Genetics Inc a clinical-stage pharmaceutical company, focuses on the development and sale of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions in the United States. The company is conducting a Phase 2 clinical study using microcatheters to deliver fulvestrant as a potential treatment of ductal carcinoma in situ and breast cancer; and a pharmaceutical program under development is Endoxifen, an active metabolite of tamoxifen, as well as treatment for breast density and other breast health conditions. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ATOS
CUSIPN/A
Phone206-325-6086

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.10 per share

Profitability

Net Income$-11,400,000.00

Miscellaneous

Employees4
Market Cap$13.06 million
Next Earnings Date3/26/2020 (Estimated)
OptionableNot Optionable

Receive ATOS News and Ratings via Email

Sign-up to receive the latest news and ratings for ATOS and its competitors with MarketBeat's FREE daily newsletter.


Atossa Genetics (NASDAQ:ATOS) Frequently Asked Questions

What is Atossa Genetics' stock symbol?

Atossa Genetics trades on the NASDAQ under the ticker symbol "ATOS."

When did Atossa Genetics' stock split? How did Atossa Genetics' stock split work?

Atossa Genetics shares reverse split on the morning of Friday, April 20th 2018. The 1-12 reverse split was announced on Friday, April 20th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 19th 2018. An investor that had 100 shares of Atossa Genetics stock prior to the reverse split would have 8 shares after the split.

How were Atossa Genetics' earnings last quarter?

Atossa Genetics Inc (NASDAQ:ATOS) posted its earnings results on Wednesday, November, 13th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.52) by $0.16. View Atossa Genetics' Earnings History.

When is Atossa Genetics' next earnings date?

Atossa Genetics is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for Atossa Genetics.

What price target have analysts set for ATOS?

1 brokerages have issued 12 month price objectives for Atossa Genetics' stock. Their forecasts range from $9.00 to $9.00. On average, they anticipate Atossa Genetics' share price to reach $9.00 in the next year. This suggests a possible upside of 529.4% from the stock's current price. View Analyst Price Targets for Atossa Genetics.

What is the consensus analysts' recommendation for Atossa Genetics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Atossa Genetics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Atossa Genetics.

Has Atossa Genetics been receiving favorable news coverage?

Press coverage about ATOS stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Atossa Genetics earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Atossa Genetics.

Are investors shorting Atossa Genetics?

Atossa Genetics saw a decline in short interest in November. As of November 29th, there was short interest totalling 330,800 shares, a decline of 12.3% from the November 14th total of 377,300 shares. Based on an average daily volume of 112,300 shares, the days-to-cover ratio is currently 2.9 days. Currently, 3.6% of the shares of the company are sold short. View Atossa Genetics' Current Options Chain.

Who are some of Atossa Genetics' key competitors?

What other stocks do shareholders of Atossa Genetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atossa Genetics investors own include Alibaba Group (BABA), Biopharmx (BPMX), AVEO Pharmaceuticals (AVEO), Heat Biologics (HTBX), Synergy Pharmaceuticals (SGYP), Gevo (GEVO), NVIDIA (NVDA), Biocept (BIOC), Protalix Biotherapeutics (PLX) and Cara Therapeutics (CARA).

Who are Atossa Genetics' key executives?

Atossa Genetics' management team includes the folowing people:
  • Dr. Steven C. Quay, Chairman, CEO & Pres (Age 68)
  • Mr. Kyle Guse CPA, Esq., CPA, CFO, Gen. Counsel & Sec. (Age 55)
  • Ms. Janet Rose Rea, Sr. VP of Regulatory, Quality & Clinical Affairs
  • Dr. Jack Cuzick, Member of Scientific Advisory Board

How do I buy shares of Atossa Genetics?

Shares of ATOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Atossa Genetics' stock price today?

One share of ATOS stock can currently be purchased for approximately $1.43.

How big of a company is Atossa Genetics?

Atossa Genetics has a market capitalization of $13.06 million. The company earns $-11,400,000.00 in net income (profit) each year or ($5.50) on an earnings per share basis. Atossa Genetics employs 4 workers across the globe.View Additional Information About Atossa Genetics.

What is Atossa Genetics' official website?

The official website for Atossa Genetics is http://www.atossagenetics.com/.

How can I contact Atossa Genetics?

Atossa Genetics' mailing address is 107 SPRING STREET, SEATTLE WA, 98104. The company can be reached via phone at 206-325-6086 or via email at [email protected]


MarketBeat Community Rating for Atossa Genetics (NASDAQ ATOS)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  166 (Vote Outperform)
Underperform Votes:  187 (Vote Underperform)
Total Votes:  353
MarketBeat's community ratings are surveys of what our community members think about Atossa Genetics and other stocks. Vote "Outperform" if you believe ATOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATOS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/14/2019 by MarketBeat.com Staff

Featured Article: What is the Coverage Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel